Published in PLoS One on February 13, 2017
Derivation of novel human ground state naive pluripotent stem cells. Nature (2013) 5.90
Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev (2001) 5.50
NGF controls axonal receptivity to myelination by Schwann cells or oligodendrocytes. Neuron (2004) 3.24
Glial specification in the vertebrate neural tube. Nat Rev Neurosci (2004) 2.75
Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. Cell Stem Cell (2013) 2.51
Signals to promote myelin formation and repair. Nat Rev Neurol (2010) 1.95
Rapid and robust generation of functional oligodendrocyte progenitor cells from epiblast stem cells. Nat Methods (2011) 1.85
Differentiation of human oligodendrocytes from pluripotent stem cells. Nat Protoc (2009) 1.83
A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells. Sci Rep (2014) 1.81
Myelination of the nervous system: mechanisms and functions. Annu Rev Cell Dev Biol (2014) 1.69
Akt and PP2A reciprocally regulate the guanine nucleotide exchange factor Dock6 to control axon growth of sensory neurons. Sci Signal (2013) 1.29
Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells. Stem Cell Reports (2014) 1.23
DMH1, a highly selective small molecule BMP inhibitor promotes neurogenesis of hiPSCs: comparison of PAX6 and SOX1 expression during neural induction. ACS Chem Neurosci (2012) 1.11
Mechanisms regulating the development of oligodendrocytes and central nervous system myelin. Neuroscience (2013) 1.10
Transgenic nonhuman primates for neurodegenerative diseases. Reprod Biol Endocrinol (2004) 1.06
Of mice and monkeys: using non-human primate models to bridge mouse- and human-based investigations of autism spectrum disorders. J Neurodev Disord (2012) 1.06
The pluripotent state in mouse and human. Development (2015) 1.05
Involvement of the Tyro3 receptor and its intracellular partner Fyn signaling in Schwann cell myelination. Mol Biol Cell (2015) 1.00
A unified cell biological perspective on axon-myelin injury. J Cell Biol (2014) 0.98
Involvement of ER stress in dysmyelination of Pelizaeus-Merzbacher Disease with PLP1 missense mutations shown by iPSC-derived oligodendrocytes. Stem Cell Reports (2014) 0.97
Glia Disease and Repair-Remyelination. Cold Spring Harb Perspect Biol (2015) 0.89
Rab35, acting through ACAP2 switching off Arf6, negatively regulates oligodendrocyte differentiation and myelination. Mol Biol Cell (2014) 0.88
Lessons from the analysis of nonhuman primates for understanding human aging and neurodegenerative diseases. Front Neurosci (2015) 0.85
Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis. Neurochem Int (2015) 0.85
Pluripotent stem cell-derived radial glia-like cells as stable intermediate for efficient generation of human oligodendrocytes. Glia (2015) 0.84
A single-cell and feeder-free culture system for monkey embryonic stem cells. PLoS One (2014) 0.82
Human fetal oligodendrocyte progenitor cells from different gestational stages exhibit substantially different potential to myelinate. Stem Cells Dev (2012) 0.82
Searching for naïve human pluripotent stem cells. World J Stem Cells (2015) 0.80
Primate models of schizophrenia: future possibilities. Prog Brain Res (2009) 0.80
Pharmacological approaches to intervention in hypomyelinating and demyelinating white matter pathology. Neuropharmacology (2015) 0.78
Cellular signaling of Dock family proteins in neural function. Cell Signal (2009) 1.10
Paxillin is the target of c-Jun N-terminal kinase in Schwann cells and regulates migration. Cell Signal (2012) 0.81
Signaling through Arf6 guanine-nucleotide exchange factor cytohesin-1 regulates migration in Schwann cells. Cell Signal (2013) 0.78
Involvement of oxidative stress and impaired lysosomal degradation in amiodarone-induced schwannopathy. Eur J Neurosci (2016) 0.75